P829: A PHASE III RANDOMIZED CLINICAL TRIAL COMPARING SB12 (PROPOSED ECULIZUMAB BIOSIMILAR) WITH REFERENCE ECULIZUMAB IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

Bibliographic Details
Main Authors:	J. H. Jang, R. Demichelis Gomez, H. Bumbea, L. Nogaieva, L. L. L. Wong, S. M. Lim, J. Park, Y. Kim, S. Cho
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000846200.39589.36

Internet